Life-saving treatments for children with orphan illnesses often move slowly, if at all, through the federal approval process.

Deciding if and when to pursue deep brain stimulation (DBS) can be overwhelming for people with Parkinson's disease. While ...

Roche's rollout of thousands of Nvidia chips is the latest example of a pharmaceutical giant trying to use AI to discover and ...

During a live event, Marc J. Braunstein, MD, PhD, and participants discussed maintenance lenalidomide and daratumumab as well as the clinical potential of MRD in multiple myeloma.

NEWARK, N.J., March 16, 2026 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL) today reported its financial results for the second quarter fiscal year 2026 ended January 31, 2026.

Because of their hormones and anatomy, women don’t experience heart disease the same way men do. Here’s what sets women’s ...

The goal in the world of global health s to bring an end to this scourge by 2030. A new drug looks as if it could do the job.

Synergy Spine CEO Josh Butters explains the Synergy Disc implant’s design, materials and a unique feature for safety.

Recent research has opened the debate on whether chemical imbalances cause depression, anxiety, and other conditions ...

ELV001 aiming to disrupt the treatment paradigm for patients with incomplete response to standard of care (methotrexate + TNF inhibitors)Phase 2b ...

Japan has approved two stem cell-based therapies for treating Parkinson's disease and heart failure in a world first, through ...

Researchers in Japan pioneered reprogrammed cells 20 years ago. Now the country has given the first-ever authorizations to manufacture and sell medical products based on the technology.